1. Analyst View
2. Research Methodology
3. APIs - An Introduction
4. Industry Performance
4.1 Current and Future Market Analysis to 2015
4.2 Market Segments
4.2.1 Branded and Generic APIs
4.2.2 Synthetic and Biotech APIs
4.3 Future Opportunity Assessment
5. Countries’ Comparative Analysis: API Manufacturing
5.1 Labor Cost and Productivity
5.2 Price Structure
5.3 Investment Cost in Plant Set-up
6. Analysis by Therapeutic Segments
6.1 Central Nervous System Disorders
6.2 Cardiovascular Diseases
6.3 Diabetes
6.4 Respiratory Disorders
6.5 Oncology
7. Key Geographical Markets
7.1 China
7.1.1 Current and Future Market Analysis to 2015
7.1.2 Regional Segmentation
7.1.3 Regulatory Environment
7.1.4 Future Opportunity Assessment
7.2 India
7.2.1 Current and Future Market Analysis to 2015
7.2.2 Regional Segmentation
7.2.3 Regulatory Environment
7.2.4 Future Opportunity Assessment
7.3 Italy
7.3.1 Current and Future Market Analysis to 2015
7.3.2 Regulatory Environment
7.3.3 Future Opportunity Assessment
7.4 Taiwan
8. High-Potency APIs: An Emerging Opportunity
9. Regulatory Environment
10. Competitive Landscape
10.1 Dr Reddy’s Laboratories
10.2 Cipla
10.3 Ranbaxy Laboratories
10.4 Zhejiang Hisun Pharmaceutical Co. Ltd.
10.5 Fabbrica Italiana Sintetici
10.6 Cambrex Corporation
10.7 Pfizer CentreSource
10.8 Teva Active Pharmaceutical Ingredients
10.9 Lonza
10.10 Daiichi Fine Chemicals